Novartis' Deal With Thais Averts License Battle
Sidestepping a potential high-profile battle over compulsory licensing, Swiss pharmaceutical giant Novartis AG has agreed to provide its cancer drug Glivec free of charge to most patients in Thailand....To view the full article, register now.
Already a subscriber? Click here to view full article